TREM2 and Alzheimer disease: Evidence from genome-wide association studies (GAWS) has shown variant of Trem2 mutations increase in risk by 3–4.5 times for developing late-onset AD [63], which is as high as the association found with ApoE-ε4 in the AD [64].